How Mayo Clinic Advances Autoimmune Neurology Testing
Artikelen konden niet worden toegevoegd
Sorry, we kunnen dit artikel niet toevoegen omdat je winkelwagen vol is.
De titel kon niet aan je winkelwagen worden toegevoegd.
Probeer het later opnieuw
De titel kon niet aan je verlanglijst worden toegevoegd.
Probeer het later opnieuw
“Uit verlanglijst verwijderen” mislukt.
Probeer het later opnieuw
“Podcast volgen” mislukt
“Podcast niet meer volgen” mislukt
-
Verteld door:
-
Van:
Over deze titel
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss a new collaboration and a Mayo Clinic-led study focused on detecting DNA mutations. Later, Dr. Pritt welcomes Andrew McKeon, M.B., B.Ch., M.D., and Anastasia Zekeridou, M.D., Ph.D., co-directors of Mayo Clinic’s Neuroimmunology Laboratory, to discuss how they are advancing patient care.
- Expanding access to advanced testing (00:32): Discover how a new collaboration with Pathology Asia Holdings will expand access to molecular and genomic testing.
- Advancing DNA mutation detection (04:50): Hear about research to detect DNA mutations across the genome and its potential implications for clinical diagnostics.
- Innovating in autoimmune neurology (07:39): Learn how the unique dynamics of the Mayo Clinic Neuroimmunology Laboratory help drive innovation.
Resources
- Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions
- Autoimmune neurology: At the forefront of a testing evolution
- Mayo Clinic Laboratories invests in Pathology Asia Holdings and LifeStrands Genomics to advance diagnostics and precision medicine
- Somatic mutations: Study advances DNA detection
adbl_web_anon_alc_button_suppression_t1
Nog geen reviews beschikbaar